Synthesis and antimicrobial evaluation of new 2-substituted 5,7-di-tert-butylbenzoxazoles
Jazyk angličtina Země Velká Británie, Anglie Médium print-electronic
Typ dokumentu časopisecké články, práce podpořená grantem
PubMed
16784871
DOI
10.1016/j.bmc.2006.05.030
PII: S0968-0896(06)00394-4
Knihovny.cz E-zdroje
- MeSH
- antibakteriální látky chemická syntéza chemie farmakologie MeSH
- benzoxazoly chemická syntéza chemie farmakologie MeSH
- buněčné linie MeSH
- chemické modely MeSH
- isoniazid farmakologie MeSH
- lidé MeSH
- mikrobiální testy citlivosti MeSH
- Mycobacterium kansasii účinky léků MeSH
- Mycobacterium tuberculosis účinky léků MeSH
- vztahy mezi strukturou a aktivitou MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Názvy látek
- antibakteriální látky MeSH
- benzoxazoly MeSH
- isoniazid MeSH
Various synthetic pathways of the 30 novel 2-substituted 5,7-di-tert-butylbenzoxazoles as new potential antimicrobial drugs are discussed. The 28 intermediates are described as well. The compounds were characterized by 1H and 13C NMR spectra, MS spectra, IR/UV spectra and by means of CHN analysis. The purity of the final compounds was checked by HPLC and their lipophilicity (log K) was also determined by means of RP-HPLC. In the present study, the correlation between RP-HPLC retention parameter log K (the logarithm of capacity factor K) and various calculated log P data is shown. The target compounds were tested for their in vitro antimycobacterial activity. Several compounds showed antituberculotic activity comparable with or higher than the standard isoniazide. In vitro cytotoxicity testing of the most active benzoxazoles and isoniazide as a reference drug was performed using MTT assay and compared with isoniazide as a reference drug. Structure-activity relationships among the chemical structures, the physical properties and the biological activities of the evaluated compounds are discussed in the article.
Citace poskytuje Crossref.org
Trifluoromethylcinnamanilide Michael Acceptors for Treatment of Resistant Bacterial Infections
Investigating biological activity spectrum for novel styrylquinazoline analogues
Salicylanilide acetates: synthesis and antibacterial evaluation